Key points are not available for this paper at this time.
These results suggest that PVN COX-2 may be an intermediary step for PVN neuronal activation and excitatory neurotransmitter release, which further contributes to sympathoexcitation and RAS activation in adriamycin-induced heart failure. Treatment with COX-2 inhibitor attenuates sympathoexcitation and RAS activation in adriamycin-induced heart failure.
Building similarity graph...
Analyzing shared references across papers
Loading...
Min Zheng
Centre National de la Recherche Scientifique
Yu‐Ming Kang
Wei Liu
PLoS ONE
SHILAP Revista de lepidopterología
Xi'an Jiaotong University
Shantou University
Shantou University Medical College
Building similarity graph...
Analyzing shared references across papers
Loading...
Zheng et al. (Tue,) studied this question.
synapsesocial.com/papers/69daba11387cf706986877b6 — DOI: https://doi.org/10.1371/journal.pone.0048771